*.*.228.27
药智数据企业版
量身打造,体验升级
立即前往
VIP试用申请
登录 注册
当前位置: 首页 > FDA溶出度方法库 反馈纠错 帮助中心
药智数据企业版注册数据库:增设了"联合申报"、"临床试验默认许可日期"等搜索条件,让搜索页面纬度更加全面,还有热点搜索和高级条件组合检索等检索功能 等你来体验!
-
药品名称 剂型 USP 溶出方法 转速(转/min) 溶出介质 容积 推荐采样时间 更新时间
Ivosidenib Tablet II (Paddle) 50 50 mM Phosphate Buffer pH, 6.8 with 0.6% sodium dodecyl sulfate (SDS), 900 10, 15, 20, 30 and 45 2020-08-27
Cysteamine Bitartrate Granule (Delayed Release) I (Basket 75 rpm (for 75 mg strength); 150 rpm (for 300 mg strength) Acid Stage: 0.1 N HCl; Buffer Stage: 0.2M Sodium Phosphate buffer, pH 6.8 Acid Stage: 120; Buffer Stage: 5, 10, 15, 20 and 30 2020-08-27
Tafenoquine Succinate Tablet II (Paddle) 75 0.01M Sodium phosphate buffer, pH 6.8, with 0.20% w/v of Polysorbate 20 900 5, 10, 20, 30, 45 and 60 2020-08-27
Amoxicillin/Omeprazole Mg./Rifabutin Capsule (Delayed Release) I (Basket 100 Amoxicillin/Rifabutin: 0.01 N HCl; Omeprazole: 0.1N HCl; Buffer Stage: 0.05M Phosphate buffer, pH 6.8 Amoxicillin/Rifabutin: 5, 10, 15, 20 and 30; Omeprazole: Acid Stage: 120; Buffer Stage: 5, 10, 15, 20 and 30; 2020-08-27
Talazoparib Tosylate Capsule II (Paddle) with sinker 75 0.01 N HCl with 0.2% sodium dodecyl sulfate (SDS), 500 10, 15, 20, 30 and 45 2020-08-27
Prucalopride Succinate Tablet II (Paddle) 50 0.1 N HCl 900 5, 10, 15, 20 and 30 2020-08-27
Triclabendazole Tablet II (Paddle) 75 0.1N HCl with 1% Tween 20 1000 5, 10, 15, 20 and 30 2020-08-27
Dapagliflozin/Saxagliptin HCl Tablet Refer to FDA's Dissolution Guidance, 2018 2020-08-27
Gilteritinib Fumarate Tablet II (Paddle) 50 0.1 N HCl 900 10, 15, 20, 30 and 45 2020-08-27
Monomethyl Fumarate Capsule (Delayed Release) II (Paddle) Stationary Basket over the Paddle 100 Acid Stage: 0.1 N HCl; Buffer Stage: Phosphate buffer, pH 6.8 Acid Stage: 120; Buffer Stage: 15, 30, 45, 60, 90, 120 and 150 2020-08-27
Amoxicillin Capsule Refer to FDA's Dissolution Guidance, 2018 2020-07-02
Alprazolam Tablet Refer to FDA's Dissolution Guidance, 2018 2020-07-02
Alosetron HCl Tablet Refer to FDA's Dissolution Guidance, 2018 2020-07-02
Anastrozole Tablet Refer to FDA's Dissolution Guidance, 2018 2020-07-02
Aliskiren Hemifumarate Tablet Refer to FDA's Dissolution Guidance, 2018 2020-07-02
Almotriptan Malate Tablet Refer to FDA's Dissolution Guidance, 2018 2020-07-02
Acalabrutinib Capsule Refer to FDA's Dissolution Guidance, 2018 2020-07-02
Albuterol Sulfate Tablet Refer to FDA's Dissolution Guidance, 2018 2020-07-02
Acarbose Tablet Refer to FDA's Dissolution Guidance, 2018 2020-07-02
Amlodipine Besylate Tablet Refer to FDA's Dissolution Guidance, 2018 2020-07-02